Category: News
Ivantis HYDRUS II Glaucoma Study Met Primary Endpoint In a Randomized Controlled Trial at 2 Years
Results from Landmark International Study Show Hydrus™ Microstent Significantly
Reduced Intraocular Pressure and Medication Use in Patients with Glaucoma
Undergoing Cataract Surgery
- 21 10 2014
- |